Share and owner information
Shares in Alligator Bioscience AB are listed on the NASDAQ OMX Nordic Exchange (Stockholm) under the designation ATORX. Companies on NASDAQ OMX Nordic Exchange are divided into three segments: Large Cap, Mid Cap and Small Cap. Nordic companies with a market value over one billion euro are presented within the Nordic Large Cap segment. Companies with a market value between 150 million and 1 billion euro are contained within the Mid Cap segment, while companies with a market value below 150 million euro are contained in the Small Cap segment. The segments are revised every six months, on 1 January and 1 July, based on the weighted average price for May and November. Alligator Bioscience is currently listed in the Mid Cap segment.
The number of ordinary shares is 71,388,615. Each share entitles the holder to one vote at the Annual General Meeting.
The 20 largest shareholders as of March 31, 2018.
No Of Shares
|Banque Internationale à Luxembourg SA||13.663.551||19.1|
|Johnson & Johnson Innovation||5.762.523||8.1|
|Sunstone Life Science Ventures Fund II K/S||5.758.485||8.1|
|Goldman Sachs & Co LLC||2.640.000||3.7|
|Atlas Antibodies AB||2.578.500||3.6|
|Öresund, Investment AB||1.757.072||2.5|
|JP Morgan fonder||956.564||1.3|
|Clearstream Banking S.A.||918.458||1.3|